Source link : https://www.newshealth.biz/health-news/year-in-review-non-small-cell-lung-cancer/
The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an unprecedented gain in progression-free survival (PFS) for ALK-positive tumors, apparent superiority of perioperative versus neoadjuvant PD-(L)1 inhibition, and using novel agents to improve the anticancer activity of immunotherapy. ‘Practice-Changing’ Results for Inoperable Disease Median PFS in unresectable, […]
Author : News Health
Publish date : 2024-11-01 15:00:00
Copyright for syndicated content belongs to the linked Source.